Paloma Partners Management CO Regeneron Pharmaceuticals, Inc. Transaction History

Paloma Partners Management CO

  • $3.08 Billion
  • Q3 2024

A detailed history of Paloma Partners Management CO transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Paloma Partners Management CO holds 625 shares of REGN stock, worth $489,068. This represents 0.02% of its overall portfolio holdings.

Number of Shares
625
Previous 600 4.17%
Holding current value
$489,068
Previous $630,000 4.29%
% of portfolio
0.02%
Previous 0.02%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$1024.09 - $1201.76 $63,493 - $74,509
62 Added 11.01%
625 $657,000
Q2 2024

Aug 14, 2024
SELL
$883.2 - $1071.19 $1.49 Million - $1.8 Million
-1,683 Reduced 74.93%
563 $591,000
Q1 2024

May 15, 2024
BUY
$902.69 - $993.35 $1.08 Million - $1.19 Million
1,197 Added 114.11%
2,246 $2.16 Million
Q4 2023

Feb 14, 2024
BUY
$775.18 - $881.7 $813,163 - $924,903
1,049 New
1,049 $921,000
Q2 2023

Aug 14, 2023
BUY
$700.03 - $830.35 $122,505 - $145,311
175 Added 117.45%
324 $232,000
Q1 2023

May 15, 2023
BUY
$680.49 - $826.97 $101,393 - $123,218
149 New
149 $122,000
Q3 2022

Nov 14, 2022
BUY
$573.97 - $724.32 $783,469 - $988,696
1,365 New
1,365 $940,000
Q2 2022

Aug 15, 2022
SELL
$548.35 - $738.84 $428,261 - $577,034
-781 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$595.12 - $698.43 $262,447 - $308,007
441 Added 129.71%
781 $546,000
Q4 2021

Feb 14, 2022
SELL
$543.48 - $670.97 $4.63 Million - $5.71 Million
-8,511 Reduced 96.16%
340 $215,000
Q3 2021

Nov 15, 2021
BUY
$574.03 - $680.96 $4.2 Million - $4.98 Million
7,315 Added 476.24%
8,851 $5.36 Million
Q2 2021

Aug 16, 2021
SELL
$472.8 - $558.54 $3.81 Million - $4.51 Million
-8,067 Reduced 84.0%
1,536 $858,000
Q1 2021

May 17, 2021
BUY
$446.73 - $548.2 $4.29 Million - $5.26 Million
9,603 New
9,603 $4.54 Million
Q2 2020

Aug 14, 2020
SELL
$493.32 - $643.92 $242,220 - $316,164
-491 Closed
0 $0
Q1 2020

May 15, 2020
SELL
$336.18 - $494.43 $446,447 - $656,603
-1,328 Reduced 73.01%
491 $240,000
Q4 2019

Feb 14, 2020
BUY
$274.13 - $376.51 $192,439 - $264,310
702 Added 62.85%
1,819 $683,000
Q3 2019

Nov 14, 2019
SELL
$273.46 - $318.39 $211,931 - $246,752
-775 Reduced 40.96%
1,117 $310,000
Q1 2019

May 15, 2019
SELL
$372.08 - $439.57 $399,241 - $471,658
-1,073 Reduced 36.19%
1,892 $777,000
Q3 2018

Nov 14, 2018
SELL
$351.14 - $408.51 $1.52 Million - $1.77 Million
-4,336 Reduced 59.39%
2,965 $1.2 Million
Q1 2018

May 15, 2018
BUY
$315.82 - $393.78 $965,145 - $1.2 Million
3,056 Added 71.99%
7,301 $2.51 Million
Q4 2017

Feb 14, 2018
BUY
$358.63 - $469.95 $1.52 Million - $1.99 Million
4,245
4,245 $1.6 Million

Others Institutions Holding REGN

# of Institutions
1,524
Shares Held
84M
Call Options Held
1.14M
Put Options Held
1.48M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $83.9B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email